HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vaccines

Suspensions of killed or attenuated microorganisms (bacteria, viruses, fungi, protozoa), antigenic proteins, synthetic constructs, or other bio-molecular derivatives, administered for the prevention, amelioration, or treatment of infectious and other diseases.
Also Known As:
Vaccine
Networked: 124365 relevant articles (14176 outcomes, 17679 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Centers for Disease Control and Prevention (CDC): 246 articles (02/2016 - 03/2000)
2. Hill, Adrian V S: 165 articles (10/2022 - 01/2002)
3. Pollard, Andrew J: 156 articles (12/2022 - 06/2002)
4. Poland, Gregory A: 141 articles (12/2022 - 01/2002)
5. Montefiori, David C: 122 articles (10/2022 - 01/2002)
6. Schlom, Jeffrey: 118 articles (11/2022 - 01/2002)
7. Rappuoli, Rino: 118 articles (01/2022 - 01/2002)
8. Klein, Nicola P: 117 articles (04/2022 - 01/2009)
9. Sette, Alessandro: 114 articles (08/2022 - 01/2002)
10. Krammer, Florian: 114 articles (06/2022 - 01/2010)

Related Diseases

1. Infections
01/01/2022 - "Vaccines are proving to be highly effective in controlling hospitalization and deaths associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, as shown by clinical trials and real-world evidence. "
01/01/2015 - "Based on our data from the presented mouse immunogenicity studies, we conclude that a killed RABV vaccine would be highly effective against HeV infections and would make an excellent vaccine candidate in areas where both RABV and henipaviruses pose a threat to human health."
06/08/2013 - "Most challenge studies demonstrate acceptable efficacy of a dual-subtype FIV vaccine (Fel-O-Vax FIV) against FIV infection under experimental settings; however, vaccine efficacy in the field still remains to be proven. "
04/18/2013 - "Nevertheless, natural immunity against CMV provides some protection against infection and disease, natural history studies have defined the serological and molecular biological techniques needed for endpoints in future clinical trials of vaccines and CMV is not highly communicable, suggesting that it may not be necessary to achieve very high levels of population immunity through vaccination in order to affect transmission. "
06/01/2011 - "By taking into account the leading role of specific cellular immunity in the development of protection against the majority of dangerous and extremely dangerous infections of bacterial, viral, and rickettsial nature, the study of the above immunity should be considered as most important on estimating the body's immunological rearrangement when vaccines against respective infections are administered. "
2. COVID-19
3. Neoplasms (Cancer)
4. Human Influenza (Influenza)
5. Tuberculosis (Tuberculoses)

Related Drugs and Biologics

1. Vaccines
2. Antigens
3. Proteins (Proteins, Gene)
4. Antibodies
5. Antiviral Agents (Antivirals)
6. Peptides (Polypeptides)
7. Epitopes
8. DNA (Deoxyribonucleic Acid)
9. Influenza Vaccines (Influenza Vaccine)
10. Neutralizing Antibodies

Related Therapies and Procedures

1. Therapeutics
2. Immunotherapy
3. Drug Therapy (Chemotherapy)
4. Injections
5. Oral Administration